Page last updated: 2024-08-25

rosiglitazone and cp 31398

rosiglitazone has been researched along with cp 31398 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Herbert, BS; Hynan, LS; Kopelovich, L; LaRue, DM; Pearce, VP; Shay, JW; Wright, WE	1

Other Studies

1 other study(ies) available for rosiglitazone and cp 31398

Article	Year
A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells. Cancer research, 2003, Apr-15, Volume: 63, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Breast; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Li-Fraumeni Syndrome; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Telomere; Thiazoles; Thiazolidinediones; Transcription Factors	2003

Article

Year

A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells.

Cancer research, 2003, Apr-15, Volume: 63, Issue:8

Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Breast; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Li-Fraumeni Syndrome; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Telomere; Thiazoles; Thiazolidinediones; Transcription Factors

2003